Distinct genomic signatures and modifiable risk factors underly the comorbidity between major depressive disorder and cardiovascular disease

Major depressive disorder (MDD) and cardiovascular disease (CVD) are often comorbid, resulting in excess morbidity and mortality. Using genetic data, this study elucidates biological mechanisms, key risk factors, and causal pathways underlying the comorbidity. We show that CVDs share a large proportion of their genetic risk factors with MDD. Multivariate genome-wide association analysis of the shared genetic liability between MDD and CVD revealed seven novel loci and distinct patterns of tissue and brain cell-type enrichments, suggesting a role for the thalamus. Part of the genetic overlap was explained by shared inflammatory, metabolic, and psychosocial risk factors. Finally, we found support for causal effects of genetic liability to MDD on CVD risk, but not vice versa, and demonstrated that the causal effects are partly explained by metabolic and psychosocial factors. The distinct signature of MDD-CVD comorbidity aligns with the idea of an immunometabolic sub-type of MDD more strongly associated with CVD than overall MDD. In summary, we identify plausible biological mechanisms underlying MDD-CVD comorbidity, as well as key modifiable risk factors for prevention of CVD in individuals with MDD.

[1]  Yun Li,et al.  Heart-brain connections: Phenotypic and genetic insights from magnetic resonance images , 2023, Science.

[2]  J. P. Hamilton,et al.  Towards a multilevel model of major depression: genes, immuno-metabolic function, and cortico-striatal signaling , 2023, Translational psychiatry.

[3]  L. Behrooz,et al.  A modern day perspective on smoking in peripheral artery disease , 2023, Frontiers in Cardiovascular Medicine.

[4]  Hong Zhang,et al.  Disrupted resting-state functional connectivity of the thalamus in patients with coronary heart disease , 2023, Heliyon.

[5]  O. Andreassen,et al.  COGEDAP: A COmprehensive GEnomic Data Analysis Platform , 2022, 2212.14103.

[6]  Trygve E Bakken,et al.  Transcriptomic diversity of cell types across the adult human brain , 2022, bioRxiv.

[7]  Z. Kutalik,et al.  Bias correction for inverse variance weighting Mendelian randomization , 2022, bioRxiv.

[8]  Audrey Y. Chu,et al.  Genome-wide association analyses of physical activity and sedentary behavior provide insights into underlying mechanisms and roles in disease prevention , 2022, Nature Genetics.

[9]  H. Stefánsson,et al.  Identification of 64 new risk loci for major depression, refinement of the genetic architecture and risk prediction of recurrence and comorbidities , 2022, medRxiv.

[10]  S. Djurovic,et al.  Shared genetic loci between depression and cardiometabolic traits , 2022, PLoS genetics.

[11]  M. Jarvelin,et al.  Genetic analysis of over half a million people characterises C-reactive protein loci , 2022, Nature Communications.

[12]  Stephen R. Williams,et al.  Stroke genetics informs drug discovery and risk prediction across ancestries , 2022 .

[13]  Christopher D. Brown,et al.  The power of genetic diversity in genome-wide association studies of lipids , 2021, Nature.

[14]  Fuquan Zhang,et al.  Shared Genetic Liability and Causal Associations Between Major Depressive Disorder and Cardiovascular Diseases , 2021, Frontiers in Cardiovascular Medicine.

[15]  M. McCarthy,et al.  Genome-Wide Association Study of Peripheral Artery Disease , 2021, Circulation. Genomic and precision medicine.

[16]  Jacob C. Ulirsch,et al.  Discovery and systematic characterization of risk variants and genes for coronary artery disease in over a million participants , 2021, Nature Genetics.

[17]  F. Fang,et al.  Disease trajectories and mortality among individuals diagnosed with depression: a community-based cohort study in UK Biobank , 2021, Molecular Psychiatry.

[18]  D. Lindqvist,et al.  Inflammatory Depression—Mechanisms and Non-Pharmacological Interventions , 2021, International journal of molecular sciences.

[19]  Tom R. Gaunt,et al.  Genome-wide association study of circulating interleukin 6 levels identifies novel loci , 2021, Human molecular genetics.

[20]  D. Posthuma,et al.  LAVA: An integrated framework for local genetic correlation analysis , 2021, bioRxiv.

[21]  M. Georgakis,et al.  Genetic Liability to Depression and Risk of Coronary Artery Disease, Myocardial Infarction, and Other Cardiovascular Outcomes , 2020, Journal of the American Heart Association.

[22]  Sathish Kumar Jayapal,et al.  Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019 , 2020, Journal of the American College of Cardiology.

[23]  P. Sham,et al.  Evaluation of bi-directional causal association between depression and cardiovascular diseases: a Mendelian randomization study , 2020, Psychological Medicine.

[24]  Kyle J. Gaulton,et al.  Multi-ancestry genetic study of type 2 diabetes highlights the power of diverse populations for discovery and translation , 2020, Nature Genetics.

[25]  Andrew H. Miller,et al.  Identifying Immunophenotypes of Inflammation in Depression: Dismantling the Monolith , 2020, Biological Psychiatry.

[26]  E. Binder,et al.  Dissecting the Association Between Inflammation, Metabolic Dysregulation, and Specific Depressive Symptoms , 2020, JAMA psychiatry.

[27]  S. Larsson,et al.  Major depressive disorder and cardiometabolic diseases: a bidirectional Mendelian randomisation study , 2020, Diabetologia.

[28]  J. Bowden,et al.  Testing and correcting for weak and pleiotropic instruments in two‐sample multivariable Mendelian randomization , 2020, bioRxiv.

[29]  Z. Kutalik,et al.  Simultaneous estimation of bi-directional causal effects and heritable confounding from GWAS summary statistics , 2020, Nature Communications.

[30]  B. Penninx,et al.  Depression Heterogeneity and Its Biological Underpinnings: Toward Immunometabolic Depression , 2020, Biological Psychiatry.

[31]  Spiros C. Denaxas,et al.  Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure , 2020, Nature Communications.

[32]  P. K. Sharma Atherosclerosis. , 2020, The Journal of the Association of Physicians of India.

[33]  L. Qi,et al.  Sleep patterns, genetic susceptibility, and incident cardiovascular disease: a prospective study of 385 292 UK biobank participants. , 2019, European heart journal.

[34]  M. Munafo,et al.  Evidence for causal effects of lifetime smoking on risk for depression and schizophrenia: a Mendelian randomisation study , 2019, Psychological Medicine.

[35]  Christopher D. Brown,et al.  The GTEx Consortium atlas of genetic regulatory effects across human tissues , 2019, Science.

[36]  Dan J Stein,et al.  Genomic influences on self-reported childhood maltreatment , 2019, bioRxiv.

[37]  Peter B. Jones,et al.  Prevalence of low-grade inflammation in depression: a systematic review and meta-analysis of CRP levels , 2019, Psychological Medicine.

[38]  N. Wray,et al.  Genetic comorbidity between major depression and cardio-metabolic disease, stratified by age at onset of major depression , 2019, bioRxiv.

[39]  Stuart J. Ritchie,et al.  Genomic SEM Provides Insights into the Multivariate Genetic Architecture of Complex Traits , 2019, Nature Human Behaviour.

[40]  Peter B. Jones,et al.  Shared mechanisms between coronary heart disease and depression: findings from a large UK general population-based cohort , 2019, bioRxiv.

[41]  A. Quyyumi,et al.  Depression and coronary heart disease: 2018 ESC position paper of the working group of coronary pathophysiology and microcirculation developed under the auspices of the ESC Committee for Practice Guidelines. , 2019, European heart journal.

[42]  Hunna J. Watson,et al.  Genetic Identification of Cell Types Underlying Brain Complex Traits Yields Novel Insights Into the Etiology of Parkinson’s Disease , 2019, bioRxiv.

[43]  Prashant S. Emani,et al.  Comprehensive functional genomic resource and integrative model for the human brain , 2018, Science.

[44]  C. Lindgren,et al.  GWAS identifies 14 loci for device-measured physical activity and sleep duration , 2018, Nature Communications.

[45]  Dajiang J. Liu,et al.  Association studies of up to 1.2 million individuals yield new insights into the genetic etiology of tobacco and alcohol use , 2018, Nature Genetics.

[46]  V. Fuster,et al.  Inflammation, Immunity, and Infection in Atherothrombosis: JACC Review Topic of the Week. , 2018, Journal of the American College of Cardiology.

[47]  Christian Gieger,et al.  Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits , 2018, Nature Genetics.

[48]  G. Smith,et al.  Invited Commentary: Detecting Individual and Global Horizontal Pleiotropy in Mendelian Randomization—A Job for the Humble Heterogeneity Statistic? , 2018, American journal of epidemiology.

[49]  Jonathan P. Beauchamp,et al.  Gene discovery and polygenic prediction from a genome-wide association study of educational attainment in 1.1 million individuals , 2018, Nature Genetics.

[50]  K. Ong,et al.  Elucidating the genetic basis of social interaction and isolation , 2018, Nature Communications.

[51]  Jay A. Montgomery,et al.  Multi-ethnic genome-wide association study for atrial fibrillation , 2018, Nature Genetics.

[52]  G. Davey Smith,et al.  Evaluating the potential role of pleiotropy in Mendelian randomization studies , 2018, Human molecular genetics.

[53]  M. Gulati,et al.  Socioeconomic Status and Cardiovascular Outcomes: Challenges and Interventions , 2018, Circulation.

[54]  P. Visscher,et al.  Meta-analysis of genome-wide association studies for height and body mass index in ∼700,000 individuals of European ancestry , 2018, bioRxiv.

[55]  S. Djurovic,et al.  Bivariate causal mixture model quantifies polygenic overlap between complex traits beyond genetic correlation , 2017, Nature Communications.

[56]  D. Posthuma,et al.  Functional mapping and annotation of genetic associations with FUMA , 2017, Nature Communications.

[57]  G. Davey Smith,et al.  Orienting the causal relationship between imprecisely measured traits using GWAS summary data , 2017, PLoS genetics.

[58]  Gerome Breen,et al.  Genetic identification of brain cell types underlying schizophrenia , 2017, Nature Genetics.

[59]  Fernando Pires Hartwig,et al.  Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption , 2017, bioRxiv.

[60]  B. Penninx Depression and cardiovascular disease: Epidemiological evidence on their linking mechanisms , 2017, Neuroscience & Biobehavioral Reviews.

[61]  N. Sheehan,et al.  Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regression: the role of the I2 statistic , 2016, International journal of epidemiology.

[62]  B. Hanratty,et al.  Loneliness and social isolation as risk factors for coronary heart disease and stroke: systematic review and meta-analysis of longitudinal observational studies , 2016, Heart.

[63]  R. Marioni,et al.  Molecular Genetic Contributions to Social Deprivation and Household Income in UK Biobank , 2016, Current Biology.

[64]  Andrew H. Miller,et al.  The role of inflammation in depression: from evolutionary imperative to modern treatment target , 2015, Nature Reviews Immunology.

[65]  Yakir A Reshef,et al.  Partitioning heritability by functional annotation using genome-wide association summary statistics , 2015, Nature Genetics.

[66]  G. Davey Smith,et al.  Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression , 2015, International journal of epidemiology.

[67]  V. Johnson-Lawrence,et al.  Race and Ethnic Group Differences in Comorbid Major Depressive Disorder, Generalized Anxiety Disorder, and Chronic Medical Conditions , 2015, Journal of Racial and Ethnic Health Disparities.

[68]  Peter Johansson,et al.  Depression and cardiovascular disease: a clinical review. , 2014, European heart journal.

[69]  M. Daly,et al.  LD Score regression distinguishes confounding from polygenicity in genome-wide association studies , 2014, Nature Genetics.

[70]  H. González,et al.  Comorbid cardiovascular disease and major depression among ethnic and racial groups in the United States , 2013, International Psychogeriatrics.

[71]  C. Nemeroff,et al.  Heartache and heartbreak—the link between depression and cardiovascular disease , 2012, Nature Reviews Cardiology.

[72]  S. Thompson,et al.  Avoiding bias from weak instruments in Mendelian randomization studies. , 2011, International journal of epidemiology.

[73]  G. Glover,et al.  Resting-State Functional Connectivity in Major Depression: Abnormally Increased Contributions from Subgenual Cingulate Cortex and Thalamus , 2007, Biological Psychiatry.

[74]  Eraldo Paulesu,et al.  Silent Ischemia as a Central Problem: Regional Brain Activation Compared in Silent and Painful Myocardial Ischemia , 1996, Annals of Internal Medicine.

[75]  C. Frith,et al.  Central nervous pathways mediating angina pectoris , 1994, The Lancet.

[76]  A. Danese,et al.  Childhood and Adolescent Adversity and Cardiometabolic Outcomes: A Scientific Statement From the American Heart Association , 2018, Circulation.

[77]  J. Barefoot Depression and coronary heart disease. , 1997, Cardiologia.